Back
Day Range
$105.88
$109.82
52-Week Range
$100.18
$143.32
Volume
666,849
50D / 200D Avg
$108.90
/
$118.14
Prev Close
$106.56
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.3 | 0.2 |
| P/B | 1.5 | 3.0 |
| ROE % | -24.5 | 3.6 |
| Net Margin % | -45.5 | 3.8 |
| Rev Growth 5Y % | -8.2 | 9.9 |
| D/E | 0.9 | 0.2 |
Analyst Price Target
Hold
$133.25
+23.2%
Low: $116.00
High: $147.00
Forward P/E
14.56
Forward EPS
$7.43
EPS Growth (est.)
+0.0%
Est. Revenue
2.41B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.07
$11.00 – $11.17
|
2.84B | 1 |
| FY2029 |
$10.04
$9.97 – $10.13
|
2.69B | 1 |
| FY2028 |
$11.76
$11.68 – $11.86
|
2.53B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | $3.76 | $1.93 | -48.7% |
| 2025-11-06 | $3.38 | $3.67 | +8.6% |
| 2025-07-31 | $3.36 | $3.73 | +11.0% |
| 2025-05-01 | $2.88 | $2.91 | +1.0% |
| 2025-02-27 | $3.86 | $3.89 | +0.8% |
| 2024-10-31 | $3.38 | $3.49 | +3.3% |
| 2024-08-01 | $3.33 | $3.42 | +2.7% |
| 2024-05-02 | $3.07 | $3.21 | +4.6% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
-0.07%
Growth (3Y)
0.00%
Growth (5Y)
0.00%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 06, 2026 | Mar 31, 2026 | $0.34 | 1.20% |
| Nov 14, 2025 | Dec 15, 2025 | $0.34 | 1.27% |
| Aug 15, 2025 | Sep 15, 2025 | $0.34 | 1.13% |
| May 20, 2025 | Jun 16, 2025 | $0.34 | 1.07% |
| Mar 07, 2025 | Mar 17, 2025 | $0.34 | 0.97% |
| Nov 15, 2024 | Dec 16, 2024 | $0.34 | 0.71% |
| Aug 15, 2024 | Sep 16, 2024 | $0.34 | 0.57% |
| May 14, 2024 | Jun 14, 2024 | $0.34 | 0.64% |
| Feb 29, 2024 | Mar 15, 2024 | $0.34 | 0.61% |
| Nov 14, 2023 | Dec 15, 2023 | $0.34 | 0.65% |
| Aug 14, 2023 | Sep 15, 2023 | $0.34 | 0.60% |
| May 12, 2023 | Jun 15, 2023 | $0.34 | 0.54% |
| Mar 02, 2023 | Mar 15, 2023 | $0.34 | 0.58% |
| Nov 14, 2022 | Dec 15, 2022 | $0.34 | 0.65% |
| Aug 12, 2022 | Sep 15, 2022 | $0.34 | 0.53% |
| May 13, 2022 | Jun 15, 2022 | $0.34 | 0.49% |
| Mar 04, 2022 | Mar 15, 2022 | $0.34 | 0.39% |
| Nov 12, 2021 | Dec 15, 2021 | $0.34 | 0.40% |
| Aug 13, 2021 | Sep 15, 2021 | $0.34 | 0.37% |
| May 13, 2021 | Jun 15, 2021 | $0.34 | 0.35% |
Key Takeaways
Revenue declined -8.23% annually over 5 years
Earnings declined -1399.81% over the past year
Generating 245.44M in free cash flow
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 26.38%
Capital efficient — spends only 4.78% of revenue on capex
Growth
Revenue Growth (5Y)
-8.23%
Revenue (1Y)-34.61%
Earnings (1Y)-1399.81%
FCF Growth (3Y)-23.48%
Quality
Return on Equity
-24.47%
ROIC3.28%
Net Margin-45.45%
Op. Margin12.84%
Safety
Debt / Equity
0.87
Current Ratio2.54
Interest Coverage2.55
Valuation
P/E Ratio
-5.28
Forward P/E14.56
P/B Ratio1.53
EV/EBITDA27.81
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -34.61% | Revenue Growth (3Y) | -18.15% |
| Earnings Growth (1Y) | -1399.81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8.23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.99B | Net Income (TTM) | -905.64M |
| ROE | -24.47% | ROA | -13.04% |
| Gross Margin | 56.24% | Operating Margin | 12.84% |
| Net Margin | -45.45% | Free Cash Flow (TTM) | 245.44M |
| ROIC | 3.28% | FCF Growth (3Y) | -23.48% |
| Safety | |||
| Debt / Equity | 0.87 | Current Ratio | 2.54 |
| Interest Coverage | 2.55 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | -0.07% |
| Dividend Growth (3Y) | 0.00% | Dividend Growth (5Y) | 0.00% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | -5.28 | Forward P/E | 14.56 |
| P/B Ratio | 1.53 | P/S Ratio | 2.40 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 27.81 | Fwd EV/EBITDA | 13.21 |
| Forward P/S | 1.98 | Fwd Earnings Yield | 6.87% |
| FCF Yield | 5.13% | ||
| Market Cap | 4.78B | Enterprise Value | 7.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.99B | 3.05B | 2.97B | 2.79B | 2.81B |
| Net Income | -905.64M | 69.68M | 356.33M | 363.14M | 485.37M |
| EPS (Diluted) | -20.25 | 1.48 | 7.53 | 7.68 | 10.23 |
| Gross Profit | 1.12B | 1.70B | 1.65B | 1.53B | 1.55B |
| Operating Income | 255.80M | 151.01M | 506.31M | 499.73M | 628.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.95B | 7.10B | 7.53B | 6.93B | 6.87B |
| Total Liabilities | 3.82B | 2.82B | 3.09B | 2.91B | 3.12B |
| Shareholders' Equity | 3.12B | 4.28B | 4.44B | 4.02B | 3.75B |
| Total Debt | 2.73B | 1.76B | 1.93B | 1.83B | 1.97B |
| Cash & Equivalents | 393.26M | 290.19M | 222.85M | 292.03M | 445.08M |
| Current Assets | 1.94B | 1.47B | 1.41B | 1.41B | 1.43B |
| Current Liabilities | 762.03M | 649.36M | 606.75M | 581.49M | 680.12M |